Noncoding RNAs in Cardiac Hypertrophy and Heart Failure

Peilei Lu, Fan Ding, Yang Kevin Xiang, Liying Hao, Meimi Zhao

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Heart failure is a major global health concern. Noncoding RNAs (ncRNAs) are involved in physiological processes and in the pathogenesis of various diseases, including heart failure. ncRNAs have emerged as critical components of transcriptional regulatory pathways that govern cardiac development, stress response, signaling, and remodeling in cardiac pathology. Recently, studies of ncRNAs in cardiovascular disease have achieved significant development. Here, we discuss the roles of ncRNAs, including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs) that modulate the cardiac hypertrophy and heart failure.

Original languageEnglish (US)
Article number777
Issue number5
StatePublished - Mar 1 2022


  • Cardiac hypertrophy
  • Heart failure
  • Noncoding RNAs

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Noncoding RNAs in Cardiac Hypertrophy and Heart Failure'. Together they form a unique fingerprint.

Cite this